tiprankstipranks
The Fly

Kronos Bio CEO Norbert Bischofberger steps down, Deborah Knobelman named interim

Kronos Bio CEO Norbert Bischofberger steps down, Deborah Knobelman named interim

Kronos Bio (KRON) announced that its Board of Directors has appointed Deborah Knobelman, Ph.D., as President and Inteim CEO, effective December 3, 2024. Dr. Knobelman will be the principal executive, financial and accounting officer. She is succeeding Norbert Bischofberger, Ph.D., who will step down as President & CEO, effective December 3, 2024. Dr. Bischofberger will remain on the Board of Directors and continue to be available to the Company as an advisor.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com